Skip to main content
Clinical Trials/IRCT20161206031256N3
IRCT20161206031256N3
Recruiting
Phase 2

Evaluation and comparison of the effect of two interferon alpha and beta antiviral drugs on the prognosis of patients with COVID 19

Mashhad University of Medical Sciences0 sites76 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
COVID-19.
Sponsor
Mashhad University of Medical Sciences
Enrollment
76
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult over 18 years
  • Clinical diagnosis of COVID\-19

Exclusion Criteria

  • History of allergy to human albumin or interferon

Outcomes

Primary Outcomes

Not specified

Similar Trials